Mutations of the Mitochondrial-tRNA Modifier MTO1 Cause Hypertrophic Cardiomyopathy and Lactic Acidosis

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 2012 May 22

PMID 22608499

Citations 100

Authors

Daniele Ghezzi

Enrico Baruffini

Tobias B Haack

Federica Invernizzi

Laura Melchionda

Cristina Dallabona

Tim M Strom

Rossella Parini

Alberto B Burlina

Thomas Meitinger

Holger Prokisch

Ileana Ferrero

Massimo Zeviani

Affiliations

Soon will be listed here.

Abstract

Dysfunction of mitochondrial respiration is an increasingly recognized cause of isolated hypertrophic cardiomyopathy. To gain insight into the genetic origin of this condition, we used next-generation exome sequencing to identify mutations in MTO1, which encodes mitochondrial translation optimization 1. Two affected siblings carried a maternal c.1858dup (p.Arg620Lysfs(∗)8) frameshift and a paternal c.1282G>A (p.Ala428Thr) missense mutation. A third unrelated individual was homozygous for the latter change. In both humans and yeast, MTO1 increases the accuracy and efficiency of mtDNA translation by catalyzing the 5-carboxymethylaminomethylation of the wobble uridine base in three mitochondrial tRNAs (mt-tRNAs). Accordingly, mutant muscle and fibroblasts showed variably combined reduction in mtDNA-dependent respiratory chain activities. Reduced respiration in mutant cells was corrected by expressing a wild-type MTO1 cDNA. Conversely, defective respiration of a yeast mto1Δ strain failed to be corrected by an Mto1(Pro622∗) variant, equivalent to human MTO1(Arg620Lysfs∗8), whereas incomplete correction was achieved by an Mto1(Ala431Thr) variant, corresponding to human MTO1(Ala428Thr). The respiratory yeast phenotype was dramatically worsened in stress conditions and in the presence of a paromomycin-resistant (P(R)) mitochondrial rRNA mutation. Lastly, in vivo mtDNA translation was impaired in the mutant yeast strains.

Citing Articles

Mitochondrial translation regulates terminal erythroid differentiation by maintaining iron homeostasis.

Morishima T, Fakruddin M, Kanamori Y, Masuda T, Ogawa A, Wang Y Sci Adv. 2025; 11(8):eadu3011.

PMID: 39983002 PMC: 11844735. DOI: 10.1126/sciadv.adu3011.

Mitochondrial tRNA modifications: functions, diseases caused by their loss, and treatment strategies.

Chujo T, Tomizawa K RNA. 2024; 31(3):382-394.

PMID: 39719325 PMC: 11874988. DOI: 10.1261/rna.080257.124.

Taurine hypomodification underlies mitochondrial tRNATrp-related genetic diseases.

Lu J, Dai Y, Ji K, Peng G, Li H, Yan C Nucleic Acids Res. 2024; 52(21):13351-13367.

PMID: 39380483 PMC: 11602126. DOI: 10.1093/nar/gkae854.

Pathological variants in nuclear genes causing mitochondrial complex III deficiency: An update.

Cunatova K, Fernandez-Vizarra E J Inherit Metab Dis. 2024; 47(6):1278-1291.

PMID: 39053894 PMC: 11586608. DOI: 10.1002/jimd.12751.

Molecular pathways in mitochondrial disorders due to a defective mitochondrial protein synthesis.

Antolinez-Fernandez A, Esteban-Ramos P, Fernandez-Moreno M, Clemente P Front Cell Dev Biol. 2024; 12:1410245.

PMID: 38855161 PMC: 11157125. DOI: 10.3389/fcell.2024.1410245.

References

COLBY G, Wu M, Tzagoloff A . MTO1 codes for a mitochondrial protein required for respiration in paromomycin-resistant mutants of Saccharomyces cerevisiae. J Biol Chem. 1998; 273(43):27945-52. DOI: 10.1074/jbc.273.43.27945. View

Invernizzi F, DAmato I, Jensen P, Ravaglia S, Zeviani M, Tiranti V . Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells. Mitochondrion. 2012; 12(2):328-35. PMC: 3314980. DOI: 10.1016/j.mito.2012.01.001. View

Nouws J, Nijtmans L, Houten S, van den Brand M, Huynen M, Venselaar H . Acyl-CoA dehydrogenase 9 is required for the biogenesis of oxidative phosphorylation complex I. Cell Metab. 2010; 12(3):283-94. DOI: 10.1016/j.cmet.2010.08.002. View

Haack T, Danhauser K, Haberberger B, Hoser J, Strecker V, Boehm D . Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat Genet. 2010; 42(12):1131-4. DOI: 10.1038/ng.706. View

Yan Q, Li X, Faye G, Guan M . Mutations in MTO2 related to tRNA modification impair mitochondrial gene expression and protein synthesis in the presence of a paromomycin resistance mutation in mitochondrial 15 S rRNA. J Biol Chem. 2005; 280(32):29151-7. PMC: 2905382. DOI: 10.1074/jbc.M504247200. View

Shi R, Villarroya M, Ruiz-Partida R, Li Y, Proteau A, Prado S . Structure-function analysis of Escherichia coli MnmG (GidA), a highly conserved tRNA-modifying enzyme. J Bacteriol. 2009; 191(24):7614-9. PMC: 2786596. DOI: 10.1128/JB.00650-09. View

Fernandez-Silva P, Acin-Perez R, Fernandez-Vizarra E, Perez-Martos A, Enriquez J . In vivo and in organello analyses of mitochondrial translation. Methods Cell Biol. 2007; 80:571-88. DOI: 10.1016/S0091-679X(06)80028-2. View

Wang X, Yan Q, Guan M . Combination of the loss of cmnm5U34 with the lack of s2U34 modifications of tRNALys, tRNAGlu, and tRNAGln altered mitochondrial biogenesis and respiration. J Mol Biol. 2009; 395(5):1038-48. PMC: 2818684. DOI: 10.1016/j.jmb.2009.12.002. View

Ghezzi D, Sevrioukova I, Invernizzi F, Lamperti C, Mora M, dAdamo P . Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor. Am J Hum Genet. 2010; 86(4):639-49. PMC: 2850437. DOI: 10.1016/j.ajhg.2010.03.002. View

10.

Prezant T, Agapian J, Bohlman M, Bu X, Oztas S, Qiu W . Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet. 1993; 4(3):289-94. DOI: 10.1038/ng0793-289. View

11.

Uusimaa J, Jungbluth H, Fratter C, Crisponi G, Feng L, Zeviani M . Reversible infantile respiratory chain deficiency is a unique, genetically heterogenous mitochondrial disease. J Med Genet. 2011; 48(10):660-668. PMC: 4562368. DOI: 10.1136/jmg.2011.089995. View

12.

Zeharia A, Shaag A, Pappo O, Mager-Heckel A, Saada A, Beinat M . Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet. 2009; 85(3):401-7. PMC: 2771591. DOI: 10.1016/j.ajhg.2009.08.004. View

13.

Cizkova A, Stranecky V, Mayr J, Tesarova M, Havlickova V, Paul J . TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy. Nat Genet. 2008; 40(11):1288-90. DOI: 10.1038/ng.246. View

14.

Zhao H, Li R, Wang Q, Yan Q, Deng J, Han D . Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am J Hum Genet. 2003; 74(1):139-52. PMC: 1181901. DOI: 10.1086/381133. View

15.

Umeda N, Suzuki T, Yukawa M, Ohya Y, Shindo H, Watanabe K . Mitochondria-specific RNA-modifying enzymes responsible for the biosynthesis of the wobble base in mitochondrial tRNAs. Implications for the molecular pathogenesis of human mitochondrial diseases. J Biol Chem. 2004; 280(2):1613-24. DOI: 10.1074/jbc.M409306200. View

16.

Mayr J, Haack T, Graf E, Zimmermann F, Wieland T, Haberberger B . Lack of the mitochondrial protein acylglycerol kinase causes Sengers syndrome. Am J Hum Genet. 2012; 90(2):314-20. PMC: 3276657. DOI: 10.1016/j.ajhg.2011.12.005. View

17.

Wang X, Yan Q, Guan M . Mutation in MTO1 involved in tRNA modification impairs mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae. Mitochondrion. 2009; 9(3):180-5. PMC: 2905380. DOI: 10.1016/j.mito.2009.01.010. View

18.

Barrientos A, Korr D, Tzagoloff A . Shy1p is necessary for full expression of mitochondrial COX1 in the yeast model of Leigh's syndrome. EMBO J. 2002; 21(1-2):43-52. PMC: 125806. DOI: 10.1093/emboj/21.1.43. View

19.

Uziel G, Ghezzi D, Zeviani M . Infantile mitochondrial encephalopathy. Semin Fetal Neonatal Med. 2011; 16(4):205-15. DOI: 10.1016/j.siny.2011.04.003. View

20.

Li X, Li R, Lin X, Guan M . Isolation and characterization of the putative nuclear modifier gene MTO1 involved in the pathogenesis of deafness-associated mitochondrial 12 S rRNA A1555G mutation. J Biol Chem. 2002; 277(30):27256-64. DOI: 10.1074/jbc.M203267200. View